Perrigo (PRGO) Enterprise Value (2012 - 2026)
Perrigo's (PRGO) quarterly Enterprise Value came in at -$357.2 million in Q1 2026, up 12.86% year-on-year from -$316.5 million in Q1 2025, and up 32.81% on a QoQ basis from -$531.6 million in Q4 2025.
Perrigo (PRGO) Enterprise Value (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Enterprise Value data on file, last reported at -$357.2 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 12.86% year-over-year to -$357.2 million in Q1 2026; TTM through Mar 2026 was -$357.2 million, a 12.86% increase from a year earlier, with the FY2025 full-year figure at -$531.6 million, up 4.87% from the prior year.
- Enterprise Value for Q1 2026 stood at -$357.2 million, up from -$531.6 million in the prior quarter.
- Over the last five years, Enterprise Value for PRGO reached as high as -$357.2 million in Q1 2026 and fell as low as -$2.0 billion in Q2 2022.
- Historically, Enterprise Value has averaged -$669.8 million across 5 years, with a median of -$553.0 million in 2023.
- On a YoY basis, Enterprise Value climbed as much as 77.45% in 2022 and fell as far as 317.39% in 2022.
- Year by year, Enterprise Value stood at -$600.7 million in 2022, then fell by 25.07% to -$751.3 million in 2023, then increased by 25.62% to -$558.8 million in 2024, then gained by 4.87% to -$531.6 million in 2025, then jumped by 32.81% to -$357.2 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$357.2 million in Q1 2026, -$531.6 million in Q4 2025, and -$432.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -357.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -357.20 Mn |
| Dec 31, 2025 | -531.60 Mn |
| Sep 27, 2025 | -432.10 Mn |
| Jun 28, 2025 | -454.20 Mn |
| Mar 29, 2025 | -409.90 Mn |
| Dec 31, 2024 | -558.80 Mn |
| Sep 28, 2024 | -1.46 Bn |
| Jun 29, 2024 | -542.80 Mn |
| Mar 30, 2024 | -658.50 Mn |
| Dec 31, 2023 | -751.30 Mn |
| Sep 30, 2023 | -598.30 Mn |
| Jul 1, 2023 | -555.20 Mn |
| Apr 1, 2023 | -553.00 Mn |
| Dec 31, 2022 | -600.70 Mn |
| Oct 1, 2022 | -468.70 Mn |
| Jul 2, 2022 | -485.30 Mn |
| Apr 2, 2022 | -1.97 Bn |
| Dec 31, 2021 | -1.86 Bn |
| Oct 2, 2021 | -2.08 Bn |
| Jul 3, 2021 | -317.50 Mn |